Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 8/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | BAX | Q07812 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL811091 | 0.94 | LTA4H (0.50) | LTA4HTSHRHTR2ASLC6A4KCNH2 | |
| SCHEMBL2774995 | 0.90 | CYP1A1 (0.52) | LTA4HTSHRHTR2ASLC6A4KCNH2 | |
| SCHEMBL20367054 | 0.89 | SLC6A4 (0.47) | LTA4HTSHRHTR2ASLC6A4KCNH2 | |
| SCHEMBL407203 | 0.81 | TEAD4 (0.54) | HTR2ASLC6A4KCNH2CYP1A2CYP1A1 | |
| SCHEMBL19490623 | 0.80 | LTA4H (0.50) | LTA4HTSHRHTTSMN1; SMN2MEN1 | |
| SCHEMBL5288147 | 0.80 | KCNA3 (0.54) | LTA4HSMN1; SMN2 | |
| SCHEMBL12871225 | 0.80 | LTA4H (0.63) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL6357397 | 0.80 | LTA4H (0.63) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL945542 | 0.80 | LTA4H (0.63) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL16705627 | 0.79 | CYP1A1 (0.44) | LTA4HHTR2ASLC6A4KCNH2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11351168-B1 | 2,4-disubstituted pyrimidines useful as kinase inhibitors | CELGENE CAR LLC (BM) | 2022-06-07 | — | — | US | disclosed |
| US-10723841-B2 | Method for preparing compound and method for preparing polymer employing the same | INDUSTRIAL TECHNOLOGY RESEARCH (TW) | 2020-07-28 | — | — | US | disclosed |
| EP-3190139-B1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | IND TECH RES INST (TW) | 2019-08-28 | — | — | EP | disclosed |
| US-10329270-B2 | Heteroaryl compounds as BTK inhibitors and uses thereof | MERCK PATENT GMBH (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20190040202-A1 | METHOD FOR PREPARING COMPOUND AND METHOD FOR PREPARING POLYMER EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2019-02-07 | — | — | US | disclosed |
| EP-2871180-B1 | 2-AMINONICOTINIC ACID ESTER DERIVATIVE AND BACTERICIDE CONTAINING SAME AS ACTIVE INGREDIENT | AGRO KANESHO CO LTD (JP) | 2018-03-21 | — | — | EP | disclosed |
| US-20170197914-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-07-13 | — | — | US | disclosed |
| US-20170197914-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-07-13 | — | — | US | disclosed |
| EP-3190139-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | Industrial Technology Research Institute (TW) | 2017-07-12 | — | — | EP | disclosed |
| EP-2823947-A1 | Method of manufacturing electrical insulating resin material and rolling bearing | JTEKT Corporation (JP) | 2015-01-14 | — | — | EP | disclosed |
| CN-100573322-C | The inorganic device in plane | 3M INNOVATIVE PROPERTIES CO (US) | 2009-12-23 | — | — | CN | disclosed |
| US-7504537-B2 | Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-03-17 | — | — | US | disclosed |
| US-7504537-B2 | Hydroxamic acid derivative and MMP inhibitor containing the same as active ingredient | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-03-17 | — | — | US | disclosed |
| CN-1688936-A | Planar inorganic device | 3M INNOVATIVE PROPERTIES CO (US) | 2005-10-26 | — | — | CN | disclosed |
| US-6207838-B1 | ELECTROLYSIS IN LIQUID SULFUR DIOXIDE | THE UNIVERSITY OF ARIZONA | 2001-03-27 | — | — | US | disclosed |
| EP-1048752-A2 | Electrochemically generated organothiating reagents and their use | ALBEMARLE CORPORATION (US) | 2000-11-02 | — | — | EP | disclosed |
| US-4120866-A | REACTING AN AROMATIC COMPOUND WITH A SULFOXIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040202-A1 | METHOD FOR PREPARING COMPOUND AND METHOD FOR PREPARING POLYMER EMPLOYING THE SAME | AR, C1S, C1R | LTA4H 1389/4885TSHR 1497/4885HTR2A 2132/4885 |
| US-20170197914-A1 | METHOD FOR PREPARING AN AROMATIC SULFIDE OR SALT THEREOF | C1S, ARSA, TST | LTA4H 1495/4885TSHR 612/4885HTR2A 4009/4885 |
| US-11351168-B1 | 2,4-disubstituted pyrimidines useful as kinase inhibitors | DCK, CDK2, DTYMK | LTA4H 3529/4885TSHR 3159/4885HTR2A 2552/4885 |
| US-10723841-B2 | Method for preparing compound and method for preparing polymer employing the same | AR, C1S, C1R | LTA4H 1389/4885TSHR 1497/4885HTR2A 2132/4885 |
| US-10329270-B2 | Heteroaryl compounds as BTK inhibitors and uses thereof | BTK, SYK, LCK | LTA4H 1446/4885TSHR 1939/4885HTR2A 2043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.